Revitalist Releases Supplement Line to Enhance the Results of Psychedelic Medicines

REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist'' or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), releases proprietary supplement lines to extend the results of psychedelic medicine outcomes.

Through a proprietary blend of vitamins, anti-inflammatories and known cognitive enhancing ingredients, Revive+ and Restore+ have been formulated to enhance psychedelic therapy.

“Providing a comprehensive wellness offering to our clients continues to be our focus. With the launch of these products, we’re building on our commitment to mental wellness offerings driven directly by research” said Kathryn Walker, Founder and CEO of Revitalist.

Benzinga reported on August 01, 2022, “28% of Americans have tried at least one psychedelic drug” showing this product is applicable to over 93 Million people. The proprietary ingredient line is combined with brain stimulating vitamins and adaptogen mushrooms to promote positive brain growth. These supplements can be taken daily with or without the combination of psychedelics.

The trademarked supplement line, “Vital+”, offers a morning supplement, “Revive+”, and an evening supplement, “Restore+”. Each supplement is $45 USD for a 30 day supply, or $72 USD for a bundled purchase of both supplements.

These products are currently available in Revitalist’s network of US clinics as well as online at RevitalistClinic.com/Vital

About Revitalist Lifestyle and Wellness, Ltd.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is one of the largest publicly listed, ketamine focused clinic operations in the United States. Each clinic enables access to psychedelic medicine, vitamin infusions and other lifestyle optimization services provided by medical and behavioral professionals. Since opening their first clinic in 2018, Revitalist has provided thousands of ketamine infusions through its network of 9 clinics operating in 6 states. Its founder and CEO, Kathryn Walker, works as a lead provider in the psychedelic space as an advanced behavioral and medical provider. For additional information please visit Revitalist.com.

On Behalf of the Board

Kathryn Walker

Chief Executive Officer

Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.

‍